Financial institution of Canada cuts fundamental rate of interest to three.25% By Investing.com
OTTAWA – To mitigate slowing financial development and a weakening job market,…
Litecoin climbs 11% on a inexperienced day By Investing.com
Investing.com - Litecoin was buying and selling at $116.966 as of 10:46…
RAMM Pharma Corp. takes inventory of disputes by Investing.com
Not for distribution in the US or through U.S. wire companies TORONTO,…
Cool Firm Inventory Hits 52-Week Low of $7.36 Amid Market Challenges By Investing.com
In a turbulent market atmosphere, Cool Firm (NYSE: CLCO) inventory hit a…
NeuroSense Aligns With FDA On Section 3 Examine Of ALS Drug By Investing.com
CAMBRIDGE, Mass. – NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a micro-cap biotechnology firm…
60 Levels Prescribed drugs Launches Scientific Trial of Babesiosis Drug By Investing.com
WASHINGTON - 60 Levels Prescribed drugs Inc. (NASDAQ: SXTP; SXTPW), an organization…
Tom Lee predicts S&P 500 will hit 7,000 by mid-2025 By Investing.com
Tom Lee, founder and head of analysis at Fundstrat International Advisors, predicts…
Leeds Group to withdraw from AIM and go personal By Investing.com
MANCHESTER, United Kingdom – Leeds Group PLC right this moment introduced the…
Rocket Prescribed drugs Costs Inventory at $12.50 By Investing.com
CRANBURY, NJ - Rocket Prescribed drugs, Inc. (NASDAQ:NASDAQ:), presently valued at $1.2…
ABVC BioPharma Secures First Money Licensing Fee of $200,000 From Oncology Product Companion, Totaling $546,000 From Three Companions Per Investing.com
FREMONT, California, December 11, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ:…
